Navigation Links
Dr. Magnus Persson Joins Cerecor's Board of Directors
Date:8/28/2012

BALTIMORE, Aug. 28, 2012 /PRNewswire/ -- Cerecor Inc. announced today that Magnus Persson, MD Ph.D. has joined the company's Board of Directors. Dr. Persson was one of the original team members at Healthcap, one of the largest biotechnology venture capital firms in Europe.  He became Partner before the first fund was raised in 1996, participated in raising in excess of US$ 1B in international institutional investments and was responsible for deal sourcing, screening and the monitoring of investments as Board representative. He invested in 85 Companies of which 24 have made successful IPO's in various European exchanges and on NASDAQ. Dr. Persson trained at the Karolinska Institute in Stockholm and prior to Healthcap led Phase II and III clinical programs in the Pharmaceutical Industry.

(Logo:  http://photos.prnewswire.com/prnh/20120411/PH85852LOGO )

Magnus currently serves on the Board of Directors of AscendxSpine (private), ConcitPharma (private), Sjalbadan (private) and the Swedish Center for Medical Nanotechnology at Karolinska Institute.  He has previously served on the Boards of Chemocentryx (public), Arpida (public), Tripep (public), PTC Therapeutics (private), Alba Therapeutics (private), Trigen (private), Apoxis (private), SpineVision (private), Carmot Therapeutics (private), MIPS Technology (private), LICA Pharmaceuticals (private), IDEA (private), Neoventa (private) and Prolifix (public).

"Magnus has a vast network within international biopharmaceutical financing communities and has a track record of delivering value for shareholders and stakeholders while expanding the potential of those people who report to him," said Blake Paterson, M.D., the CEO of Cerecor.   Dr. Persson added, "I am delighted to join the Board of Directors of Cerecor and to assist its outstanding management in building a novel and truly differentiated neuroscience Company."

In addition to Drs. Persson and Paterson, Cerecor's Board is Chaired by Dr. Sol Barer and further comprised of members Dr. Gene Bauer and Mssrs. Isaac Blech, John Catsimatidis, and Cary Sucoff.

About Cerecor:  Cerecor Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of prescription pharmaceuticals whose primary activity is in the human nervous system. We are a Delaware corporation, based in Baltimore and organized in April 2011 in partnership with various laboratories at Johns Hopkins Medical Institute. Cerecor is focused on translational medicine – the accelerated transfer of technology from the academic laboratory to early human trials, with the mission of commercializing therapeutics that make a difference.

Contact:  John Dierkes, Kennedy Advisors, +1-410-522-8707


'/>"/>
SOURCE Cerecor Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Joseph Rogers Joins SRI International as Executive Director of New Health Sciences Section in Biosciences Division
2. Pharmacy Industry Veteran Joins Millennium Pharmacy Systems as SVP Operations
3. Biotechnology Thought Leader, Dr. Abbie Celniker, Joins ImaginAb Board of Directors as Chairman
4. Dr. Gerald Yakatan Joins Imprimis Pharmaceuticals Science and Regulatory Advisory Board
5. MinuteClinic Joins with American Heart Association to Help Americans Reduce High Blood Pressure
6. Stephen G. Austin, CPA Joins Imprimis Pharmaceuticals Board Of Directors
7. Remedy Informatics Joins LongView International Technology Solutions Team to Win CIO-SP3 Contract Award
8. Tara Dall, MD Joins Health Diagnostic Laboratory (HDL, Inc.) as Chief Medical Officer
9. Double Helix Joins McCann Health
10. Prairie Education & Research Cooperative Joins MedNet Solutions iMedNet CRO Partner Program
11. Don Hubbard Joins Checkpoint Surgical As VP Of Sales And Marketing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/17/2017)... Management to Discuss Acquisition of ... KIT-302 Development On Track For An NDA ... Q1 2017   ... Holdings Ltd. (NASDAQ: KTOV ; TASE: KTOV), an innovative biopharmaceutical company, ... rd at 8:30am Eastern Time to discuss the recent acquisition of a ...
(Date:1/17/2017)... Pharmaceuticals plc (Nasdaq: JAZZ ) today announced that ... 3 clinical trial comparing the efficacy and safety of ... of hepatic veno-occlusive disease (VOD) in adult and pediatric ... at high risk or at very high risk of ... across approximately 100 medical centers in the ...
(Date:1/17/2017)... , Jan. 17, 2017  Edwards Lifesciences Corporation ... patient-focused innovations for structural heart disease and critical care ... quarter ended December 31, 2016 after the market closes ... conference call at 5:00 p.m. ET that day to ... conference call, dial (877) 407-8037 or (201) 689-8037.  For ...
Breaking Medicine Technology:
(Date:1/17/2017)... ... 17, 2017 , ... Peoples Health is pleased to announce ... Dec. 1, 2016. Peoples Health, a Metairie-based Medicare Advantage company, serves more than ... to our provider network, and the addition will benefit our members in the ...
(Date:1/17/2017)... ... January 17, 2017 , ... A prescription medication bottle, pocket knife, luggage and ... to Cradle Product Design Challenge , the Cradle to Cradle Products Innovation Institute ... design challenges scheduled to run through early 2018. The challenges are presented by the ...
(Date:1/17/2017)... (PRWEB) , ... January 17, 2017 , ... Neil H. ... financial planning assistance to communities throughout the region, is launching a charity drive to ... disease is by far the deadliest killer in America, and is responsible for 1 ...
(Date:1/17/2017)... ... January 17, 2017 , ... SC&H Group, a leading ... a Principal in its IT Advisory Services practice . Rossi is the third ... market demand for strategic IT guidance grows, and the practice continues to expand.     , ...
(Date:1/17/2017)... ... January 17, 2017 , ... ... and eliminate cyber threats in real-time, today announced a strategic partnership with ... Selangor, Malaysia. Joining other Seceon partners, TechLab Security has become a strategic partner ...
Breaking Medicine News(10 mins):